William F. Pierce
- Oncology top 5%
- HER2/EGFR in Cancer Research 8
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Advanced Breast Cancer Therapies 6
- Prostate Cancer Treatment and Research 3
- Renal cell carcinoma treatment 2
- Cancer Research top 10%
- Breast Cancer Treatment Studies 4
- Hepatology top 10%
- Co-authors
- Richard PazdurShenghui TangPaul G. KluetzKirsten B. GoldbergLaleh Amiri‐KordestaniAmna IbrahimMarc R. TheoretJulia A. Beaver
- Journals
- Journal of Clinical Oncology (5 papers)Clinical Cancer Research (15 papers)European Journal of Neuroscience (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
William F. Pierce
23 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 594
- Radiology, Nuclear Medicine and Imaging 315
- Pulmonary and Respiratory Medicine 393
- Cancer Research 162
- Hepatology 73
Countries citing papers authored by William F. Pierce
This map shows the geographic impact of William F. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Pierce more than expected).
Fields of papers citing papers by William F. Pierce
This network shows the impact of papers produced by William F. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Pierce. The network helps show where William F. Pierce may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William F. Pierce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 14 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 34 | |
| 10 | FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancerbreakdown → | 2022 | 127 |
| 11 | 2022 | 56 | |
| 12 | 2021 | 118 | |
| 13 | 2020 | 16 | |
| 14 | 2020 | 8 | |
| 15 | 2018 | 88 | |
| 16 | 2018 | 75 | |
| 17 | 2017 | 1 | |
| 18 | 2012 | 77 | |
| 19 | 2011 | 34 | |
| 20 | The Career Education Concept. | 1973 | 1 |
About William F. Pierce
William F. Pierce is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Emergency Medical Services, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Breast Cancer Treatment Studies (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Prostate Cancer Treatment and Research (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (594 citations), Radiology, Nuclear Medicine and Imaging (315 citations) and Pulmonary and Respiratory Medicine (393 citations). William F. Pierce has collaborated with scholars based in United States and Japan. Frequent co-authors include Richard Pazdur, Shenghui Tang, Paul G. Kluetz, Kirsten B. Goldberg, Laleh Amiri‐Kordestani, Amna Ibrahim, Marc R. Theoret, Julia A. Beaver, Rajeshwari Sridhara and Todd R. Palmby. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.